Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.
about
Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmacological characterizati ...... ent insulin secretion ex vivo.
@en
type
label
Pharmacological characterizati ...... ent insulin secretion ex vivo.
@en
prefLabel
Pharmacological characterizati ...... ent insulin secretion ex vivo.
@en
P2093
P2860
P356
P1476
Pharmacological characterizati ...... ent insulin secretion ex vivo.
@en
P2093
K F McClure
K O Cameron
S K Bhattacharya
S V Straub
P2860
P304
P356
10.1111/BPH.13439
P407
P577
2016-01-19T00:00:00Z